Alternatives to Latus Bio
Latus Bio is a Biotechnology tool: engineering scalable gene therapies for broader patient populations. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Latus Bio
- Website
Jazz Pharmaceuticals24BiotechnologyDublin, Ireland$265.0MGlobal biopharmaceutical company focused on oncology and neuroscience treatments.
- Website SASana Biotechnology47BiotechSeattle, United States
Biotechnology company developing cell and gene therapies for serious diseases.
- Website
C4 Therapeutics49BiotechBoston, United States$371.0MBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
Houdini Bio42BiotechnologyCambridge, United Kingdom$1.7MEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
- Website
Laverock Therapeutics41BiotechnologyCambridge, United Kingdom$10.0MDeveloping disease-responsive advanced therapies through programmable gene control technology.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
BreezeBio58BiotechnologyAlameda, US$93.5MBreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.
- Website
Verve Therapeutics56BiotechnologyCambridge, USA$300.0MDeveloping gene editing therapies to lower cholesterol.
- Website
Sinopia Biosciences54BiotechnologySan Diego, USA$2.2MBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
- Website SPSpliceBio54BiotechnologyCambridge, United States$100.0M
Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
Qureight53BiotechnologyCambridge, United Kingdom$20.0MAn end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.
Showing the 20 closest matches. See the rest on the Latus Bio profile.
Compare Latus Bio head to head
Side by side on what each one does, what it costs, and what real users report.